1. Home
  2. ASR vs HALO Comparison

ASR vs HALO Comparison

Compare ASR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASR
  • HALO
  • Stock Information
  • Founded
  • ASR 1996
  • HALO 1998
  • Country
  • ASR Mexico
  • HALO United States
  • Employees
  • ASR N/A
  • HALO N/A
  • Industry
  • ASR Aerospace
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ASR Consumer Discretionary
  • HALO Health Care
  • Exchange
  • ASR Nasdaq
  • HALO Nasdaq
  • Market Cap
  • ASR 7.8B
  • HALO 6.4B
  • IPO Year
  • ASR 2000
  • HALO N/A
  • Fundamental
  • Price
  • ASR $276.05
  • HALO $48.78
  • Analyst Decision
  • ASR Buy
  • HALO Buy
  • Analyst Count
  • ASR 4
  • HALO 9
  • Target Price
  • ASR $274.00
  • HALO $61.11
  • AVG Volume (30 Days)
  • ASR 48.6K
  • HALO 1.5M
  • Earning Date
  • ASR 10-22-2024
  • HALO 10-31-2024
  • Dividend Yield
  • ASR 6.44%
  • HALO N/A
  • EPS Growth
  • ASR 23.91
  • HALO 61.71
  • EPS
  • ASR 2.16
  • HALO 3.02
  • Revenue
  • ASR $1,490,558,036.00
  • HALO $947,355,000.00
  • Revenue This Year
  • ASR $18.66
  • HALO $23.36
  • Revenue Next Year
  • ASR $17.41
  • HALO $15.15
  • P/E Ratio
  • ASR $12.85
  • HALO $16.09
  • Revenue Growth
  • ASR 11.33
  • HALO 21.35
  • 52 Week Low
  • ASR $248.88
  • HALO $33.15
  • 52 Week High
  • ASR $357.90
  • HALO $65.53
  • Technical
  • Relative Strength Index (RSI)
  • ASR 58.87
  • HALO 46.87
  • Support Level
  • ASR $258.00
  • HALO $47.55
  • Resistance Level
  • ASR $278.77
  • HALO $48.88
  • Average True Range (ATR)
  • ASR 6.53
  • HALO 1.20
  • MACD
  • ASR 1.88
  • HALO 0.30
  • Stochastic Oscillator
  • ASR 89.00
  • HALO 63.47

About ASR Grupo Aeroportuario del Sureste S.A. de C.V.

Grupo Aeroportuario del Sureste SAB de CV operates airports in southeast Mexico. The company's segments include Cancun; Aerostar; Airplan; Merida; Villahermosa; Holding and Services and other. It generates maximum revenue from the Cancun segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: